Sun Pharmaceutical Industries described the acquisition as a strategic investment to strengthen its product portfolio.
Sun Pharmaceutical Industries announced its plan to acquire 100% share in Invocare Lifesciences. This strategic acquisition is valued at Rs 271 crore. Sun Pharma aims to strengthen its product portfolio through this significant investment, enhancing its market presence and…
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.